Daniel W Muehl Clovis Oncology, Inc. (CLVS) insider trading activity

Daniel W Muehl is Officer of Clovis Oncology, Inc.. Currently has a direct ownership of 104,830 shares of CLVS, which is worth approximately $9,434. The most recent transaction as insider was on May 01, 2021, when has been sold 10,248 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 105K

0% 3M change

0% 12M change

Total Value Held $9,434

DANIEL W MUEHL Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 01 2021	BUY Exercise of conversion of derivative security	-	10,248 Added 15.37%	56,425 Common Stock
Mar 02 2021	BUY Exercise of conversion of derivative security	-	1,032 Added 2.11%	47,815 Common Stock
Mar 01 2021	SELL Open market or private sale	$2,868 $6.29 p/Share	456 Reduced 0.95%	47,566 Common Stock
Feb 02 2021	SELL Open market or private sale	$94,620 $7.97 p/Share	11,872 Reduced 20.17%	46,990 Common Stock
Feb 01 2021	BUY Exercise of conversion of derivative security	-	24,125 Added 30.02%	56,244 Common Stock
Dec 03 2020	SELL Open market or private sale	$2,235 $4.89 p/Share	457 Reduced 1.3%	34,737 Common Stock
Dec 03 2020	BUY Exercise of conversion of derivative security	-	1,031 Added 2.86%	34,986 Common Stock
Nov 03 2020	SELL Open market or private sale	$12,493 $4.93 p/Share	2,534 Reduced 6.91%	34,163 Common Stock
Nov 03 2020	BUY Exercise of conversion of derivative security	-	5,623 Added 13.66%	35,545 Common Stock

DWM

Daniel W Muehl

Officer

Boulder, CO

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLVS shares.

Notify only if

Value

Insider Trading

Get notified when an Clovis Oncology, Inc. insider buys or sells CLVS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Clovis Oncology, Inc.

Track Activities on CLVS

Account